Citi Downgrades Medivation (MDVN) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. IVBIY
9. SPY
10. FIX

Go back to Citi Downgrades Medivation (MDVN) to Neutral

Brean Capital Downgrades Medivation (MDVN) to Hold

August 22, 2016 1:01 PM EDT

Brean Capital downgraded Medivation (NASDAQ: MDVN) from Buy to Hold.

For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.

Shares of Medivation closed at $67.16 yesterday.

... More

Wedbush Downgrades Medivation (MDVN) to Neutral

August 22, 2016 1:00 PM EDT

Wedbush downgraded Medivation (NASDAQ: MDVN) from Outperform to Neutral.

For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.

Shares of Medivation closed at $67.16 yesterday.

... More

Pfizer (PFE) to Acquire Medivation (MDVN) in $14B Deal

August 22, 2016 6:45 AM EDT

Pfizer Inc. (NYSE: PFE) and Medivation, Inc. (Nasdaq: MDVN) announced that they have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company focused on developing and commercializing small molecules for oncology, for $81.50 a share in cash for a total enterprise value of approximately $14 billion. The Boards of Directors of both companies have unanimously approved the merger, which is expected to be immediately accretive to Pfizers Adjusted Diluted EPS upon closing, approximately $0.05 accretive in the first full year after close with... More